22nd Century Group, Inc. (22nd Century Group) through its subsidiary, 22nd Century Limited, LLC (22nd Century Ltd), which is a plant biotechnology company. The Company focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. Goodrich Tobacco Company, LLC (Goodrich Tobacco) and Hercules Pharmaceuticals, LLC (Hercules Pharmaceuticals) are subsidiaries of 22nd Century Ltd. Goodrich Tobacco is focused on commercial tobacco products and potentially reduced-risk or modified risk tobacco products. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development. In September 2014, the Company acquired NASCO Products, LLC.